Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9380759 | Journal of Affective Disorders | 2005 | 13 Pages |
Abstract
On the basis of available evidence, it is not possible to identify the most cost-effective strategy for alleviating the symptoms of depression, although the SSRIs and newer antidepressants consistently appear more cost-effective than tricyclic antidepressants in many patient groups. Better quality economic evidence is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Barbara Barrett, Sarah Byford, Martin Knapp,